Interview with Dr. Isabel Fortier
When I was little, I was fascinated by the way the human body works. Later I decided to study biology to find out more about it, and I went into epidemiology for my doctorate...
A prescription with legs!
A study from the Research Institute of the McGill University Health Centre (RI-MUHC) shows that physician-delivered step count...
What is high Lipoprotein(a), and should I be concerned?
A team of researchers from the Research Institute of the McGill University Health Center (RI-MUHC) found that elevations in a unusual...
A race against time to diagnose deadly weight loss in cancer patients
About one third of cancer patients die because of cachexia – an involuntary weight loss, characterized primarily by muscle wasting and metabolic changes, which cannot be addressed or treated solely...
Inappropriate and overuse of antibiotics in fight against tuberculosis in India
Simulated patient study sheds new light on antibiotic use in India
Critical years ahead in fight against hepatitis C virus
In the last five years, new drugs have revolutionized the treatment of hepatitis C (HCV), a virus that causes serious liver disease.
MUHC expert Dr. Mark Ware appointed vice-chair of federal task force on legalization of cannabis
World-renowned pain specialist and medical cannabis researcher Dr. Mark Ware, director of clinical research at the Alan Edwards Pain Management Unit of the McGill University...
McGill University installs inaugural Chair in Pharmacoepidemiology
Dr. Robert Platt, Professor in the departments of Pediatrics and Epidemiology, Biostatistics and Occupational Health at McGill University’s Faculty of Medicine was officially announced...
Antidepressants: rise in off-label prescriptions
Antidepressant use in North America has increased over the last 2 decades. A suspected reason for this trend is that primary care physicians are increasingly prescribing...